China SXT Pharmaceuticals (SXTC) Assets Average (2018 - 2026)

China SXT Pharmaceuticals (SXTC) has reported Assets Average for 9 consecutive years, with $30.6 million the latest figure, recorded in Q1 2026.

• Quarterly Assets Average rose 16.04% year-over-year to $30.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.6 million (up 16.04% YoY) and the FY2026 annual result came in at $28.2 million, up 25.96% from the prior year.
• Assets Average climbed to $30.6 million in Q1 2026 per SXTC's latest filing, from $24.0 million in the prior quarter.
• Over the last five years, Assets Average for SXTC reached as high as $30.6 million in Q1 2026 and fell as low as $18.9 million in Q1 2024.
• A 5-year average of $25.6 million and a median of $26.3 million in 2025 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2024 — Assets Average dropped 27.1% — and 2025, when it soared 39.63%.
• Year by year, Assets Average stood at $27.9 million in 2022, then fell by 20.79% to $22.1 million in 2023, then grew by 22.61% to $27.1 million in 2024, then decreased by 11.28% to $24.0 million in 2025, then grew by 27.26% to $30.6 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $30.6 million, $24.0 million, and $26.3 million for Q1 2026, Q3 2025, and Q1 2025 respectively.